HER
Beyond's analysis on HER
Recent news mentioning HER
- — Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
- — Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
- — Wall Street Is Worried About AMD. Here’s Why Long-Term Investors Shouldn’t Be
- — Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
- — Interview: „Das wäre die Zerstörung der CDU“: Oettinger warnt vor Annäherung an die AfD
- — Elon Musk Owns 28% of Tesla, a Stake Worth Nearly $350 Billion. Here's Why His Ownership Level Matters for Shareholders.
- — Making $80K vs. $150K: Where the Extra Money Actually Goes
- — We Asked ChatGPT To Pick Between Tesla and Apple Stock — Here's What It Chose
- — I Asked ChatGPT If High Interest Rates Are Good for Retirees — Here's the Truth
- — Volkswagen-Werk Osnabrück: Israels »Iron Dome« soll Standort sichern
- — Why Does Amazon Trade at a Discount to Walmart and Costco? Here's the Only Answer That Makes Sense.
- — Summer Broke The Script. Here's What CRE Is Walking Back Into